» Articles » PMID: 30681575

Association of BAX Hypermethylation with Coronary Heart Disease is Specific to Individuals Aged over 70

Overview
Specialty General Medicine
Date 2019 Jan 26
PMID 30681575
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: As a member of B-cell lymphoma-2 (BCL-2) gene family, BCL-2 associated X (BAX) is important for cell apoptosis. In this work, we investigated the association of BAX promoter DNA methylation with coronary heart disease (CHD) in Han Chinese.

Methods: A SYBR green-based quantitative methylation specific PCR (qMSP) was used to test BAX methylation levels in 959 CHD cases and 514 controls.

Results: Although BAX methylation was not associated with CHD in the total samples, further breakdown analysis by age showed that BAX hypermethylation was significantly associated with CHD for individuals aged over 70 (median percentage of methylation ratio [PMR], 10.70% in cases versus (vs) 2.25% in controls, P =.046). Moreover, BAX methylation was associated with smoking and lipoprotein A (Lp(a)) for individuals aged over 70 (CHD: smoking P = .012, Lp(a) P = .001; non-CHD: smoking P = .051, Lp(a) P = .004). Further analysis of Gene Expression Omnibus (GEO) and The Cancer Genome Atlas (TCGA) data showed BAX expression was upregulated by 5-aza-2'-deoxycytidine demethylation agent (fold = 1.66, P = .038) and inversely correlated with BAX methylation (r = -0.428, P = 8E-05).

Conclusions: Our study supported that BAX hypermethylation might contribute to CHD risk via downregulation of BAX expression for individuals aged over 70.

Citing Articles

Epigenetic remodeling in heart failure with preserved ejection fraction.

Ambrosini S, Gorica E, Mohammed S, Costantino S, Ruschitzka F, Paneni F Curr Opin Cardiol. 2022; 37(3):219-226.

PMID: 35275888 PMC: 9415220. DOI: 10.1097/HCO.0000000000000961.


A male-specific association between AGTR1 hypermethylation and coronary heart disease.

Li X, Wu N, Ji H, Huang Y, Hu H, Li J Bosn J Basic Med Sci. 2019; 20(1):31-36.

PMID: 31538912 PMC: 7029202. DOI: 10.17305/bjbms.2019.4321.

References
1.
Huang Y, Ye H, Gao X, Nie S, Hong Q, Ji H . Significant interaction of APOE rs4420638 polymorphism with HDL-C and APOA-I levels in coronary heart disease in Han Chinese men. Genet Mol Res. 2015; 14(4):13414-24. DOI: 10.4238/2015.October.28.3. View

2.
Florath I, Butterbach K, Muller H, Bewerunge-Hudler M, Brenner H . Cross-sectional and longitudinal changes in DNA methylation with age: an epigenome-wide analysis revealing over 60 novel age-associated CpG sites. Hum Mol Genet. 2013; 23(5):1186-201. PMC: 3919014. DOI: 10.1093/hmg/ddt531. View

3.
Bell J, Tsai P, Yang T, Pidsley R, Nisbet J, Glass D . Epigenome-wide scans identify differentially methylated regions for age and age-related phenotypes in a healthy ageing population. PLoS Genet. 2012; 8(4):e1002629. PMC: 3330116. DOI: 10.1371/journal.pgen.1002629. View

4.
Schiano C, Vietri M, Grimaldi V, Picascia A, De Pascale M, Napoli C . Epigenetic-related therapeutic challenges in cardiovascular disease. Trends Pharmacol Sci. 2015; 36(4):226-35. DOI: 10.1016/j.tips.2015.02.005. View

5.
Chen R, Hong Q, Jiang J, Chen X, Jiang Z, Wang J . promoter hypermethylation in lung squamous cell carcinoma but not in lung adenocarcinoma. Oncol Lett. 2017; 14(4):4989-4994. PMC: 5649578. DOI: 10.3892/ol.2017.6824. View